Experimental procedures for synthesis of Fmoc-Lys(Moc)-OH, Fmoc-Lys(Hoc)-OH
anhydride (Ac 2 O) were purchased from Wako Chemicals (Osaka, Japan) and used without further purification. 2,6-Lutidine was purchased from Tokyo Kasei (Tokyo, Japan) and used without further purification. Fmoc-NH-PEG5-COOH was purchased from Merck (Darmstadt, Germany) and used without further purification. Distilled water was used throughout the synthesis.
1 H NMR spectra of the fluorescent amino acids were recorded on a Mercury 300 spectrometer (Varian). MALDI-TOF masses of the peptide oligomers were recorded on a Voyager DE Pro (Applied Biosystem).
Synthesis of Fmoc-Lys(Moc)-OH
Fmoc-Lys-OH・HCl (70.3 mg, 174 μmol) was mixed with 7-methoxycoumarin-3-carboxylic acid, SE (50.0 mg, 158 μmol) in acetonitrile/0.2M NaHCO 3 aq. (=2/1 v/v) at room temperature overnight.
Then the mixture was purified with HPLC (acetonitrile/0.1% TFA aq.) and dried in vacuo.
Fmoc-Lys(Moc)-OH was obtained as a white powder (84 mg, 93%): 1 H NMR (300MHz, DMSO-d 6 ) δ 1.37 (m, 2H, Lys γ -CH 2 -), 1.52 (m, 2H, Lys δ -CH 2 -), 1.64 (m, 2H, Lys β -CH 2 -), 3.30 (m, 2H, Lys ε -CH 2 -), 3.88 (s, 3H, Coumarin (7)-C-OCH 3 ), 3.92 (m, 1H, Lys α -CH-), 4.1-4.3 (m, 3H, Fmoc -CH-CH 2 -), 6.994, 7.003, 7.024, 7.031 (q, 1H, Coumarin (6) Then the mixture was purified with HPLC (acetonitrile/0.1% TFA aq.) and dried in vacuo.
Fmoc-Lys(Hoc)-OH was obtained as a white powder (107 mg, quant.):
1 H NMR (300MHz, 
